| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192019 | Annals of Allergy, Asthma & Immunology | 2012 | 7 Pages |
Abstract
Persistent small airways dysfunction occurs despite treatment at steps 2 through 4 of current asthma guidelines. Extra-fine ICS may reduce airway resistance at step 2. Prospective studies with extra-fine ICS ± LABA at steps 2 through 4 are required to discern whether improving small airways function might result in long-term improved control.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
William J. MBChB, Emma BSc, Brian J. MD,